Sashegyi, A : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (44)
Les plus populaires
Liste
- Liste
- Tableau

1

Closed Reduction and Intramedullary Pinning of Radial Neck Fractures in Children

Béla Novoth, Károly Fekete, Ernõ Hargitai, Tamás Kassai, Tamás Kõvári, Mihály Sashegyi

Journal:

Orthopedics and Traumatology

Année:

2002

Langue:

english

Fichier:

PDF, 212 KB

english, 2002

2

Die perkutane intramedulläre Reposition und Stabilisierung dislozierter Radiushalsfrakturen im Wachstumsalter

Béla Novoth, Károly Fekete, Ernõ Hargitai, Tamás Kassai, Tamás Kõvári, Mihály Sashegyi

Journal:

Operative Orthopädie und Traumatologie

Année:

2002

Fichier:

PDF, 221 KB

2002

3

Risk-Benefit Profile for Raloxifene: 4-Year Data From the Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial

Elizabeth Barrett-Connor, Jane A Cauley, Pandurang M Kulkarni, Andreas Sashegyi, David A Cox, Mary Jane Geiger

Journal:

Journal of Bone and Mineral Research

Année:

2004

Langue:

english

Fichier:

PDF, 90 KB

english, 2004

4

Predictive Probability of Success and the Assessment of Futility in Large Outcomes Trials

Trzaskoma, Benjamin, Sashegyi, Andreas

Journal:

Journal of Biopharmaceutical Statistics

Année:

2007

Langue:

english

Fichier:

PDF, 209 KB

english, 2007

5

Application of a Generalized Random Effects Regression Model for Cluster-correlated Longitudinal Data to a School-based Smoking Prevention Trial

Sashegyi, A. I.

Journal:

American Journal of Epidemiology

Année:

2000

Langue:

english

Fichier:

PDF, 112 KB

english, 2000

6

On the correspondence between population-averaged models and a class of cluster-specific models for correlated binary data

Andreas I. Sashegyi, K.Stephen Brown, Patrick J. Farrell

Journal:

Statistics & Probability Letters

Année:

2001

Langue:

english

Fichier:

PDF, 208 KB

english, 2001

7

International INtegrated Database for the Evaluation of severe sePsis and drotrecogin alfa (activated) THerapy: component trials and statistical methods for INDEPTH

Sashegyi, Andreas, Trzaskoma, Benjamin L., Nelson, David R., Williams, Mark D., Macias, William

Journal:

Current Medical Research and Opinion

Année:

2006

Langue:

english

Fichier:

PDF, 509 KB

english, 2006

8

Broncho-pulmonary lesions associated with tuberculous lymph NODE compression—‘Node compression syndrome’

I. Malatinszky, B. Sashegyi

Journal:

Année:

1970

Fichier:

PDF, 1.43 MB

1970

9

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety

Pierre-Francois Laterre, David R. Nelson, William Macias, Edward Abraham, Andreas Sashegyi, Mark D. Williams, Mitchell Levy, Marcel Levi, Barbara Utterback, Jean-Louis Vincent

Journal:

Journal of Critical Care

Année:

2007

Langue:

english

Fichier:

PDF, 458 KB

english, 2007

10

Role of tumor necrosis factor-α and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women

Brian W Walsh, David A Cox, Andreas Sashegyi, Robert A Dean, Russell P Tracy, Pamela W Anderson

Journal:

The American Journal of Cardiology

Année:

2001

Langue:

english

Fichier:

PDF, 115 KB

english, 2001

11

Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial

Nanette Kass Wenger, Elizabeth Barrett-Connor, Peter Collins, Deborah Grady, Marcel Kornitzer, Lori Mosca, Andreas Sashegyi, Simin K Baygani, Pamela W Anderson, Elena Moscarelli

Journal:

The American Journal of Cardiology

Année:

2002

Langue:

english

Fichier:

PDF, 163 KB

english, 2002

12

Raloxifene and cardiovascular events in osteoporotic postmenopausal women. Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial

E. Barrett-Connor, D. Grady, A. Sashegyi

Journal:

ACC Current Journal Review

Année:

2002

Langue:

english

Fichier:

PDF, 35 KB

english, 2002

13

Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes

Elizabeth Barrett-Connor, Kristine E. Ensrud, Kristine Harper, Timothy M. Mason, Andreas Sashegyi, Kathryn A. Krueger, Pamela W. Anderson

Journal:

Clinical Therapeutics

Année:

2003

Langue:

english

Fichier:

PDF, 876 KB

english, 2003

14

Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women

Pamela W Anderson, David A Cox, Andreas Sashegyi, Sofia Paul, Sheryl L Silfen, Brian W Walsh

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 148 KB

english, 2001

15

On the initialization of tropical cyclones with a three dimensional variational analysis

Chi-Sann Liou, Keith D. Sashegyi

Journal:

Natural Hazards

Année:

2012

Langue:

english

Fichier:

PDF, 2.17 MB

english, 2012

16

Modified tensor fascia lata musculofasciocutaneous flap for the coverage of trochanteric pressure sores

J. Jósvay, M. Sashegyi, P. Kelemen, A. Donáth

Journal:

Journal of Plastic, Reconstructive & Aesthetic Surgery

Année:

2006

Langue:

english

Fichier:

PDF, 209 KB

english, 2006

17

Estimation in an Empirical Bayes Model for Longitudinal and Cross-Sectionally Clustered Binary Data

Andreas I. Sashegyi, K. Stephen Brown and Patrick J. Farrell

Journal:

Canadian Journal of Statistics

Année:

2000

Langue:

english

Fichier:

PDF, 2.36 MB

english, 2000

18

A Portfolio-Based Approach to Optimize Proof-of-Concept Clinical Trials

Mallinckrodt, Craig, Molenberghs, Geert, Persinger, Charles, Ruberg, Stephen, Sashegyi, Andreas, Lindborg, Stacy

Journal:

Journal of Biopharmaceutical Statistics

Année:

2012

Langue:

english

Fichier:

PDF, 134 KB

english, 2012

19

Year-by-year analysis of cardiovascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial*

Keech, Cheryl A., Sashegyi, Andreas, Barrett-Connor, Elizabeth

Journal:

Current Medical Research and Opinion

Année:

2005

Langue:

english

Fichier:

PDF, 391 KB

english, 2005

20

Combining Information for Quantitative Decision-making in Drug Development

Beck, Benoît, Iversen, Phil, Sashegyi, Andreas

Journal:

Journal of Multi-Criteria Decision Analysis

Année:

2014

Langue:

english

Fichier:

PDF, 980 KB

english, 2014

21

Statistical refocusing in the design of Phase II trials offers promise of increased R&D productivity

Lindborg, Stacy R., Persinger, Charles C., Sashegyi, Andreas, Mallinckrodt, Craig, Ruberg, Stephen J.

Journal:

Nature Reviews Drug Discovery

Année:

2014

Langue:

english

Fichier:

PDF, 1.09 MB

english, 2014

22

Comment on: Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies

Sashegyi, Andreas, Lin, Yong, Ferry, David, Melemed, Allen

Journal:

Clinical Drug Investigation

Année:

2015

Langue:

english

Fichier:

PDF, 356 KB

english, 2015

23

Adaptive Design and Decision Analysis--Companions for Transforming Clinical Development

Journal:

Therapeutic Innovation & Regulatory Science

Année:

2008

Langue:

english

Fichier:

PDF, 5.22 MB

english, 2008

24

Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal Women

Barrett-Connor, Elizabeth, Grady, Deborah, Sashegyi, Andreas, Anderson, Pamela W., Cox, David A., Hoszowski, Krzysztof, Rautaharju, Pentti, Harper, Kristine D., for the MORE Investigators,

Journal:

JAMA The Journal of the American Medical Association

Année:

2002

Langue:

english

Fichier:

PDF, 160 KB

english, 2002

25

Raloxifene Does Not Affect Insulin Sensitivity or Glycemic Control in Postmenopausal Women with Type 2 Diabetes Mellitus: A Randomized Clinical Trial

Andersson, Björn, Johannsson, Gudmundur, Holm, Goran, Bengtsson, Bengt-Ake, Sashegyi, Andreas, Pavo, Imre, Mason, Timothy, Anderson, Pamela W.

Journal:

Journal of Clinical Endocrinology & Metabolism

Année:

2002

Langue:

english

Fichier:

PDF, 106 KB

english, 2002

26

Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials

Sashegyi, Andreas, Zhang, Yawei, Lin, Yong, Binder, Polina, Ferry, David

Journal:

Journal of Chemotherapy

Année:

2016

Langue:

english

Fichier:

PDF, 480 KB

english, 2016

27

A Benefit-risk Model to Facilitate DMC-sponsor Communication and Decision Making

Sashegyi, Andreas

Journal:

Drug Information Journal

Année:

2011

Langue:

english

Fichier:

PDF, 908 KB

english, 2011

28

Clinical Experience With the Hatchet-Shaped Gluteus Maximus Musculocutaneous Flap

J??svay, J??nos, Sashegyi, Mih??ly, Kelemen, P??ter, Don??th, Antal

Journal:

Annals of Plastic Surgery

Année:

2005

Langue:

english

Fichier:

PDF, 531 KB

english, 2005

29

Application of Vertical-Mode Initialization to a Limited-Area Model in Flux Form

Sashegyi, Keith D., Madala, Rangarao V.

Journal:

Monthly Weather Review

Année:

1993

Fichier:

PDF, 1.06 MB

1993

30

Coupled Assimilation of Geostationary Satellite Sounder Data into a Mesoscale Model Using the Bratseth Analysis Approach

Ruggiero, Frank H., Sashegyi, Keith D., Lipton, Alan E., Madala, Rangarao V., Raman, Sethu

Journal:

Monthly Weather Review

Année:

1999

Langue:

english

Fichier:

PDF, 497 KB

english, 1999

31

A Numerical Study of the ERICA IOP 4 Marine Cyclone

Chang, Simon W., Holt, Teddy R., Sashegyi, Keith D.

Journal:

Monthly Weather Review

Année:

1996

Fichier:

PDF, 1.97 MB

1996

32

On the Interpretation of the Hazard Ratio and Communication of Survival Benefit

Sashegyi, Andreas, Ferry, David

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 188 KB

english, 2017

33

Is neutropenia a prognostic or a predictive factor for second line metastatic colorectal cancer (mCRC) patients (Pts)? Exploratory analysis from RAISE, a randomized, double-blind, phase III study of ramucirumab (RAM) + FOLFIRI vs placebo (PBO) + FOLFIRI

Ciuleanu, T.-E., Bodoky, G., Garcia-Carbonero, R., García Alfonso, P., Van Cutsem, E., Muro, K., Mytelka, D., Lipkovich, O., Ferry, D., Sashegyi, A., Nasroulah, F., Tabernero, J.

Journal:

Annals of Oncology

Année:

2016

Langue:

english

Fichier:

PDF, 42 KB

english, 2016

34

MA 03.06 Effect of 2L Ramucirumab after Rapid Time to Progression on 1L Therapy: Subgroup Analysis of REVEL in Advanced NSCLC

Reck, M., Shepherd, F., Pérol, M., Cappuzzo, F., Shih, J., Park, K., Winfree, K., Alexandris, E., Lee, P., Sashegyi, A., Garon, E.

Journal:

Journal of Thoracic Oncology

Année:

2017

Langue:

english

Fichier:

PDF, 112 KB

english, 2017

35

Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting

Reck, Martin, Garassino, Marina Chiara, Imbimbo, Martina, Shepherd, Frances A., Socinski, Mark A., Shih, Jin-Yuan, Tsao, Anne, Lee, Pablo, Winfree, Katherine B., Sashegyi, Andreas, Cheng, Rebecca, Var

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 490 KB

english, 2018

36

INDEPTH DATABASE OF SEVERE SEPSIS PATIENTS SHOWS FEWER CARDIAC EVENTS IN DROTRECOGIN ALFA (ACTIVATED) PATIENTS VS PLACEBO PATIENTS

Heiselman, Darell, Lowry, Stephen, Dhainaut, Jean-Francois, Laterre, Pierre-Francois, Schein, Roland, Seneff, Michael, Sollet, Jean-Pierre, Artigas, Antonio, Janes, Jonathan, Booth, Frank, Sashegyi, A

Journal:

Année:

2005

Langue:

english

Fichier:

PDF, 123 KB

english, 2005

37

1592PMeta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab

Arnold, D., Fuchs, C.S., Tabernero, J., Ohtsu, A., Zhu, A.X., Garon, E.B., Paz-Ares, L., Baron, A.D., Okusaka, T., Yoshino, T., Yoon, H.H., Das, M., Ferry, D., Zhang, Y., Lin, Y., Binder, P., Sashegyi

Journal:

Annals of Oncology

Année:

2017

Langue:

english

Fichier:

PDF, 79 KB

english, 2017

38

P1.13-30 Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor and its Relationship to NSCLC Patient Outcomes in the REVEL Trial

Garon, E., Tsao, A., Reck, M., Levy, B., Visseren-Grul, C., Mao, H., Sashegyi, A., Chaudhry, A.

Journal:

Journal of Thoracic Oncology

Année:

2018

Fichier:

PDF, 263 KB

2018

39

120PSubgroup analysis of adenocarcinoma patients refractory to first-line chemotherapy from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non–small cell lung cancer (NSCLC)

Reck, M., Paz-Ares, L., Moro-Sibilot, D., Shepherd, F.A., Cappuzzo, F., Winfree, K.B., Alexandris, E., Sashegyi, A., Varea, R., Pérol, M.

Journal:

Annals of Oncology

Année:

2017

Fichier:

PDF, 76 KB

2017

40

E3Subgroup analysis of patients (Pts) refractory to first-line (1L) chemotherapy from REVEL, a randomized phase 3 study of docetaxel (DOC) with ramucirumab (RAM) or placebo (PBO) for second-line (2L) treatment of stage IV non-small-cell lung cancer (NSCLC)

Reck, M, Paz-Ares, L, Pérol, M, Johnson, M, Pennell, N, Novello, S, Cappuzzo, F, Bidoli, P, Zimmermann, A, Lee, P, Sashegyi, A, Varea Menendez, R

Journal:

Annals of Oncology

Année:

2017

Fichier:

PDF, 124 KB

2017

41

PD-005Analysis of weight loss as a prognostic factor in patients with advanced gastric cancer from the Phase 3 RAINBOW study

Mansoor, W, Roeland, E, Abraham, M, Wei, R, Chatterjee, A, Sashegyi, A, Desai, A, Abada, P, Chaudhry, A, Klempner, S

Journal:

Annals of Oncology

Année:

2019

Fichier:

PDF, 76 KB

2019

42

1413TiP LIBRETTO-431: Selpercatinib in treatment (Tx)-naÃ¯ve patients with RET fusion-positive (RET+) non-small cell lung cancer (NSCLC)

Loong, H.H.F., Goto, K., Elamin, Y.Y., Solomon, B., Santini, F.C., Soldatenkova, V., Sashegyi, A., Lin, A. Bence, Lin, B.K., Wolf, J., Oxnard, G.R., Zhou, C., Drilon, A., Park, K.

Journal:

Annals of Oncology

Année:

2020

Fichier:

PDF, 69 KB

2020

43

Phase III study of selpercatinib vs chemotherapy +/â pembrolizumab in untreated RET positive non-small-cell lung cancer

Solomon, Benjamin J, Zhou, Cai Cun, Drilon, Alexander, Park, Keunchil, Wolf, JÃ¼rgen, Elamin, Yasir, Davis, Hannah M, Soldatenkova, Victoria, Sashegyi, Andreas, Lin, Aimee Bence, Lin, Boris K, F Loong

Journal:

Future Oncology

Année:

2020

Fichier:

PDF, 1.93 MB

2020

44

1927TiP LIBRETTO-531: Selpercatinib in patients with treatment (Tx)-naÃ¯ve RET-mutant medullary thyroid cancer (MTC)

Hernando, J., Tarasova, V., Hu, M.I., Sherman, E.J., Brose, M.S., Robinson, B., Tahara, M., Wirth, L.J., Sashegyi, A., Soldatenkova, V., Lin, B.K., Wright, J., Hoff, A.O., Leboulleux, S., Elisei, R.,

Journal:

Annals of Oncology

Année:

2020

Fichier:

PDF, 79 KB

2020